NDC11 58468022501
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 58468-0225-01 | 58468-0225 |
| 58468-0225-1 | 58468-0225 |
| 58468-225-01 | 58468-225 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cablivi | CAPLACIZUMAB | Genzyme Corporation | 2348f06e-8004-4040-832e-e9e86a39f905 | 2026-04-24 | Warnings, Adverse reactions | 58468-0225-1 58468-0225 58468022501 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.